Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis

Journal of Immunology

Volumn 174, Issue 3, 2005, Pages 1616-1620

  Benjamin, Claudia F ^a   Canetti, Claudio ^a   Cunha, Fernando Q ^b   Kunkel, Steven L ^a   Peters Golden, Marc ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [3 (4 BIPHENYLYLMETHYL) 4 HYDROXYCHROMAN 7 YL]CYCLOPENTANECARBOXYLIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE; LACTIC ACID; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR; PEPTIDOLEUKOTRIENE; VERLUKAST;

ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BLOOD VESSEL REACTIVITY; CELL MIGRATION; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HYPOTENSION; IMMUNE RESPONSE; INNATE IMMUNITY; KNOCKOUT MOUSE; LACTATE BLOOD LEVEL; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PERITONITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SEPSIS; SURVIVAL; WILD TYPE;

EID: 12444255105     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.3.1616     Document Type: Article

References (39)

1. Benjamim, C. F., C. M. Hogaboam, N. W. Lukacs, and S. L. Kunkel. 2003. Septic mice are susceptible to pulmonary aspergillosis. Am. J. Pathol. 163:2605.
2. Bone, R. C., C. J. Grodzin, and R. A. Balk. 1997. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235.
3. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546.
4. Henderson, W. R., Jr. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:684.
5. Henderson, W. R., Jr. 1994. Role of leukotrienes in asthma. Ann. Allergy 72:272.
6. Lewis, R. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323:645.
7. Bailie, M. B., T. J. Standiford, L. L. Laichalk, M. J. Coffey, R. Stricter, and M. Peters-Golden. 1996. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumoniae in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol. 157:5221.
8. Mancuso, P., P. Nana-Sinkam, and M. Peters-Golden. 2001. Leukotriene B4 augments neutrophil phagocytosis of Klebsiella pneumoniae. Infect. Immun. 69:2011.
9. Mancuso, P., T. J. Standiford, T. Marshall, and M. Peters-Golden. 1998. 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect. Immun. 66:5140.
10. Dahlen, S. E., J. Bjork, P. Hedqvist, K. E. Arfors, S. Hammarstrom, J. A. Lindgren, and B. Samuelsson. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA 78:3887.
11. Ueno, A., K. Tanaka, M. Katori, M. Hayashi, and Y. Arai. 1981. Species difference in increased vascular permeability by synthetic leukotriene C4 and D4. Prostaglandins 21:637.
12. Can, C., M. G. Cinar, S. Ulker, A. Evinc, and S. Kosay. 1998. Effects of MK-886, a leukotriene biosynthesis inhibitor, in a rabbit model of endotoxic shock. Eur. J. Pharmacol. 350:223.
13. Fletcher, J. R. 1993. Eicosanoids: critical agents in the physiological process and cellular injury. Arch. Surg. 128:1192.
14. Chen, X. S., J. R. Shelter, E. N. Johnson, and C. D. Funk. 1994. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372:179.
15. Baker, C. C., I. H. Chaudry, H. O. Gaines, and A. E. Baue. 1983. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331.
16. Fang, M., K. J. Kovacs, L. L. Fisher, and A. A. Larson. 2003. Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin. J. Physiol. 549:903.
17. Yepes, M., M. Sandkvist, E. O. Moore, T. H. Bugge, D. K. Strickland, and D. A. Lawrence. 2003. Tissue-type plasminogen activator induces opening of the blood-brain barrier via LDL receptor-related protein. J. Clin. Invest. 112:1483.
18. Whitesall, S. E., J. B. Hoff, A. P. Vollmer, and L. G. D'Alecy. 2004. Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods. Am. J. Physiol. Heart Circ. Physiol. 286:H2408.
19. Krege, J. H., J. B. Hodgin, J. R. Hagaman, and O. Smithies. 1995. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 25:1111.
20. 4 mediate the neutrophil migration in immune inflammation. Br. J. Pharmacol. 134:1619.
21. 4 receptor antagonist, MK-571, in mice: possible involvement of opioidergic mechanism. Eur. J. Pharmacol. 386:195.
22. Jeng, J. C., K. Jablonsfci, A. Bridgeman, and M. H. Jordan. 2002. Serum lactate, not base deficit, rapidly predicts survival after major burns. Burns 28:161.
23. Burka, J. F., and P. Eyre. 1977. A pharmacological study of SRS-A on the bovine cutaneous vasculature. Can. J. Physiol. Pharmacol. 55:904.
24. Williams, T. J., and P. J. Piper. 1980. The action of chemically pure SRS-A on the microcirculation in vivo. Prostaglandins 19:779.
25. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420:885.
26. Anderson, M. R., and J. L. Blumer. 2000. Prognostic markers in sepsis: the role of leukotrienes. Crit. Care Med. 28:3762.
27. Rios-Santos, F., C. F. Benjamim, D. Zavery, S. H. Ferreira, and F. Q. Cunha. 2003. A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligaton and puncture sepsis. Shock 19:61.
28. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644.
29. Beutler, B., and A. Poltorak. 2001. Sepsis and evolution of the innate immune response. Crit. Care Med. 29:52.
30. Goulet, J. L., J. N. Snouwaert, A. M. Latour, T. M. Coffman, and B. H. Koller. 1994. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA 91:12852.
31. Peters-Golden, M., M. Bailie, T. Marshall, C. Wilke, S. H. Phan, G. B. Toews, and B. B. Moore. 2002. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am. J. Respir. Crit. Care Med. 165:229.
32. Armstrong, R. A. 1995. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils. Br. J. Pharmacol. 116:2903.
33. Standiford, T. J., S. L. Kunkel, M. W. Rolfe, H. L. Evanoff, R. M. Allen, and R. M. Stricter. 1992. Regulation of human alveolar macrophage- and blood monocyte-derived interleukin-8 by prostaglandin E2 and dexamethasone. Am. J. Respir. Cell Mol. Biol. 6:75.
34. Kunkel, S. L., M. Spengler, M. A. May, R. Spengler, J. Larrick, and D. Remick. 1988. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263:5380.
35. Strassmann, G., V. Patil-Koota, F. Finkelman, M. Fong, and T. Kambayashi. 1994. Evidence for the involvement of interleukm 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180:2365.
36. Kamohara, M., J. Takasaki, M. Matsumoto, S. Matsumoto, T. Saito, T. Soga, H. Matsushime, and K. Furuichi. 2001. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells. Biochem. Biophys. Res. Commun. 287:1088.
37. Luchtefeld, M., H. Drexler, and B. Schieffer. 2003. 5-Lipoxygenase is involved in the angiotensin II-induced NAD(P)H-oxidase activation. Biochem. Biophys. Res. Commun. 308:668.
38. Sakada, K., S. E. Dahlen, and M. Back. 2004. The contractile action of leukotriene B4 in the guinea-pig lung involves a vascular component. Br. J. Pharmacol. 141:449.
39. Byrum, R. S., J. L. Goulet, J. N. Snouwaert, R. J. Griffiths, and B. H. Koller. 1999. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. J. Immunol. 163:6810.